Bausch + Lomb Corporation - SIC # 3851 - OPHTHALMIC GOODS

Ticker Exchange SIC # Website Latest Ticker
BLCO New York 3851 www.bausch.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Bausch + Lomb Corporation

Bausch + Lomb's Dry Eye Disease Prescription Momentum Builds, Forex Turns as Modest Headwind in Q3, RBC Says - Oct 8th, 2026 8:51 am
3 Low-Volatility Stocks with Open Questions - Oct 8th, 2026 2:32 am
Flutter upgraded, AppFolio downgraded: Wall Street's top analyst calls - Oct 7th, 2026 8:00 am
Bausch + Lomb Advances Novel Oral Treatment for Dry AMD Following Constructive FDA Meeting - Oct 6th, 2026 2:30 pm
Bausch + Lomb Will Release Third-Quarter 2026 Financial Results on Oct. 28 - Oct 5th, 2026 5:30 am
SpyGlass Pharma Acquires Advanced Vision Science, Inc. (AVS), Securing Scalable Commercial IOL Supply and Accelerating Lens Portfolio Expansion Capability - Oct 1st, 2026 6:00 am
3 Small-Cap Stocks That Concern Us - Sep 17th, 2026 3:46 am
Robinson Pharma, Inc. Receives "Above and Beyond" Supplier Award from Bausch + Lomb for September 2026 - Sep 16th, 2026 4:24 pm
BLCO Gains European CE Mark for Next-Gen SeeLyra Femtosecond Laser - Sep 14th, 2026 9:14 am
Bausch + Lomb Announces European CE Mark Approval of SeeLyra™ Femtosecond Laser - Sep 11th, 2026 4:11 am
1 Cash-Producing Stock with Exciting Potential and 2 We Ignore - Sep 9th, 2026 7:30 am
Bausch + Lomb Announces New Published Research on enVista Aspire™ Real World Experience - Sep 2nd, 2026 5:00 am
Most Women Don't Recognize Dry Eye as a Symptom of Perimenopause and Menopause, New Bausch + Lomb Survey Finds - Sep 1st, 2026 4:58 am
Bausch + Lomb (BLCO) Stock Trades Below Fair Value As Caution Lingers - Aug 29th, 2026 5:06 pm
1 Unpopular Stock That Deserves a Second Chance and 2 We Turn Down - Aug 28th, 2026 5:12 am
3 Healthcare Stocks We Steer Clear Of - Aug 27th, 2026 8:33 am
Zepbound may cut healthcare costs, study says; Summit, Akeso drug hits in another China trial - Aug 26th, 2026 4:11 am
A Look Back at Medical Devices & Supplies - Specialty Stocks’ Q2 Earnings: Bausch + Lomb (NYSE:BLCO) Vs The Rest Of The Pack - Aug 25th, 2026 10:54 am
Bausch + Lomb Advances Two First-in-Class Eye Health Therapies - Aug 25th, 2026 9:53 am
Bausch + Lomb Advances Dry Eye Drug to Phase III as Pain Candidate Hits Phase Ib Goal - Aug 24th, 2026 7:01 pm